Literature DB >> 8545291

Soluble interleukin-2 receptor in patients with glomerular diseases.

H S Chen1, M S Wu, T S Yen, W Y Chen.   

Abstract

In this study, we measured the soluble interleukin-2 receptor (sIL-2R) level to evaluate the cellular immune status in 61 patients with different types of glomerular diseases; 40 healthy volunteers were used as control. All patients with glomerular diseases had levels of serum sIL-2R significantly higher than those of the controls (766 +/- 59 vs 280 +/- 23 U/ml; p < 0.05). Even patients with normal renal function still had higher serum sIL-2R levels than the controls, no matter to which subgroups they belonged (primary glomerulonephritis, lupus nephritis or diabetic nephropathy). Serum sIL-2R levels were similar among the three subgroups. The serum levels of sIL-2R correlated well with age and were significantly higher in older patients, although this was not observed in the control group. Serum sIL-2R levels were significantly higher in patients with active urinary sediment and in patients with impaired renal function and showed a significant negative correlation with creatinine clearance (r = -0.56; p < 0.05). Although urinary and serum sIL-2R levels were quite well correlated, (r = 0.35; p < 0.05), the urinary levels of sIL-2R did not differ in patients with different disease activity or different renal functions although they had a significant correlation with 24-hour urinary protein (r = 0.39; p < 0.05). Patients with nephrotic syndrome also had higher urinary sIL-2R levels than other patients (529 +/- 106 vs 280 +/- 31 U/ml; p < 0.05). We conclude that greater T-cell activation might contribute to the pathogenesis of different glomerulonephritis entities, and serum levels of sIL-2R can serve as a useful clinical marker of glomerulonephritis activity. Renal function influenced the serum levels of sIL-2R significantly. This factor must be considered when we interpret the data. Urinary sIL-2R levels did not reflect the disease activity as well. This might be due to the secondary influence of the extent of the glomerular protein leak. Further investigation is needed to define the exact excretory pathway of this substance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545291      PMCID: PMC2398256          DOI: 10.1136/pgmj.71.840.617

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  20 in total

1.  Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes.

Authors:  J H Helderman; T B Strom
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

2.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

Review 3.  Cellular immunity in glomerulonephritis.

Authors:  H M Fillit; J B Zabriskie
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

4.  Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis.

Authors:  C Y Tsai; T H Wu; K H Sun; W M Lin; C L Yu
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

5.  The role of interleukin 2 (IL-2) and serum-soluble IL-2 receptor cells in idiopathic IgA nephropathy.

Authors:  M Parera; F Rivera; J Egido; A Campos
Journal:  Clin Immunol Immunopathol       Date:  1992-05

6.  Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes.

Authors:  L Alviggi; C Johnston; P J Hoskins; D E Tee; D A Pyke; R D Leslie; D Vergani
Journal:  Lancet       Date:  1984-07-07       Impact factor: 79.321

7.  In vitro regeneration of resting lymphocytes from stimulated lymphocytes and its inhibition by insulin.

Authors:  J Kumagai; H Akiyama; S Iwashita; H Iida; I Yahara
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

8.  Soluble interleukin-2 receptor levels in lupus nephritis.

Authors:  J Laut; D Senitzer; R Petrucci; L B Sablay; P Barland; D Glicklich
Journal:  Clin Nephrol       Date:  1992-10       Impact factor: 0.975

9.  Soluble interleukin-2 receptors and beta 2-microglobulin in patients with primary glomerulonephritis.

Authors:  C Rollino; D Roccatello; M C Amprimo; G Cavalli; G Aimo; G Beltrame; B Basolo; G Martina; G Piccoli
Journal:  Am J Nephrol       Date:  1993       Impact factor: 3.754

10.  Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity.

Authors:  W H Schmitt; C Heesen; E Csernok; A Rautmann; W L Gross
Journal:  Arthritis Rheum       Date:  1992-09
View more
  1 in total

Review 1.  Role of the adaptive immune system in diabetic kidney disease.

Authors:  Lingyun Kong; Sofianos Andrikopoulos; Richard J MacIsaac; Laura K Mackay; David J Nikolic-Paterson; Niloufar Torkamani; Neda Zafari; Evelyn C S Marin; Elif I Ekinci
Journal:  J Diabetes Investig       Date:  2021-12-21       Impact factor: 4.232

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.